HSE report shows price of a pack of medicines in Ireland reducing

13 April 2015

Trade group the Irish Pharmaceutical Healthcare Association (IPHA) has said that a report published by the Health Services Executive (HSE) this week shows that the average price of a pack of medicine provided to patients through the community drugs schemes decreased to its lowest level in a decade.

Commenting on the report that was published last week, the IPHA said it evaluates the HSE’s Primary Care Reimbursement Service, which administers the delivery of a wide range of primary care services to the general public. The report shows that the average price of a pack of medicine reimbursed through the community drugs schemes in 2013 was lower than average prices in the previous 10 years.

Savings delivered by pharma industry a major factor in price reductions

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK